Pediatrix Medical
322 hedge funds and large institutions have $3.91B invested in Pediatrix Medical in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 113 increasing their positions, 119 reducing their positions, and 50 closing their positions.
46% more call options, than puts
Call options by funds: $14.2M | Put options by funds: $9.71M
5% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 119
2.01% less ownership
Funds ownership: 97.51% → 95.5% (-2%)
6% less funds holding
Funds holding: 342 → 322 (-20)
24% less capital invested
Capital invested by funds: $5.12B → $3.91B (-$1.21B)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
32% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 50
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCP
P2 Capital Partners
New York
|
+$86.1M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$55M |
| 3 |
D.E. Shaw & Co
New York
|
+$28.6M |
| 4 |
O
OrbiMed
New York
|
+$23.6M |
| 5 |
Morgan Stanley
New York
|
+$22.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$76.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$48.1M |
| 3 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
-$33.3M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$33.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$31M |
MD Hedge Fund Activity: Q2 2018 in Review
322 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2018, worth a combined $3.91B — down 24% from $5.12B a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of MD and 34 opened new positions — a net loss of 16 holders — while 119 trimmed existing stakes and 113 added.
The largest buyer was P2 Capital Partners, opening a new position worth an estimated $86.1M. The largest seller was HealthCor Management, exiting entirely with an estimated $76.9M sold.
- 322 institutional investors held Pediatrix Medical (MD) as of Q2 2018, down from 342 in Q1 2018.
- Funds reported $3.91B of Pediatrix Medical stock for Q2 2018, down 24% quarter-over-quarter.
- 34 funds opened new Pediatrix Medical positions in Q2 2018 and 50 closed out, a net change of -16 holders.
- The largest Pediatrix Medical buyer in Q2 2018 was P2 Capital Partners, an estimated $86.1M added.
- The largest Pediatrix Medical seller in Q2 2018 was HealthCor Management, an estimated $76.9M sold.
Based on aggregated 13F filings for Q2 2018.